Clinical Trial Update: Beyond 12 Hours Reperfusion AlternatiVe Evaluation Trial [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating beyond-12-hours reperfusion strategies for myocardial infarction has completed. No trial results or drug specifics are provided in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED